Organization · Venture Capital
Bold Brain Capital
Bold Brain Capital is a venture capital firm based in Durham, North Carolina, specializing in early-stage investments in AI-enabled healthcare companies. The firm leverages a proprietary network of physicians to enhance its investment strategy.
Overview
What Bold Brain Capital does
What Bold Brain Capital is
Bold Brain Capital is a venture capital firm based in Durham, North Carolina, specializing in early-stage investments in AI-enabled healthcare companies. The firm leverages a proprietary network of physicians to enhance its investment strategy.
How it participates in the startup ecosystem
The current public profile supports funder and community capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder · Community
- Last reviewed
- April 22, 2026
Official channels
Find Bold Brain Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Bold Brain Capital as a funder
Investment thesis
Bold Brain Capital is an early-stage venture capital firm focused on AI-enabled healthcare, leveraging a network of physician investors to enhance the development and deployment of medical AI technologies.
Focus narrative
The firm invests primarily in early-stage life sciences companies that are pioneering AI technologies in healthcare. Bold Brain Capital emphasizes the importance of physician involvement in the development of medical AI, believing that such collaboration is crucial for creating clinically useful and deployable solutions. The firm typically participates in Seed through Series C funding rounds.
Value beyond capital
Bold Brain Capital provides significant value to its portfolio companies through its proprietary Bold Brain Network, which consists of hundreds of physician investors. This network not only co-invests alongside the firm but also aids in sourcing and conducting due diligence on potential investments. Additionally, the firm offers consulting opportunities within its portfolio companies, leveraging the expertise of its physician partners to enhance product development and market fit.
Focus and fit
- Stages
- Seed · Series A · Series B · Series C
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Vista.ai: AI solution for enhancing cardiac imaging efficiency in MRI scans. Koios Medical: Ultrasound image analysis platform for cancer diagnosis using AI. Inference Analytics: Deep learning platform that improves physician productivity through enhanced understanding of radiology reports. Elucid: Cardiovascular diagnostic software evaluating atherosclerotic plaque stability. Segmed: Curates medical datasets for AI development in medical imaging. CureMetrix: AI-driven solutions for improving cancer detection in mammography. A.I. Analysis Inc.: Machine learning solutions to enhance radiology practices. Bunkerhill: Platform for clinical validation and deployment of AI models in radiology.
Capability profile
Bold Brain Capital as a community
Community overview
Bold Brain Capital is a venture capital firm based in Durham, North Carolina, dedicated to facilitating physician involvement in the development of AI-enabled healthcare companies. Founded in 2018, the firm focuses on investing in early-stage life sciences companies that are pioneering disruptive AI technologies. By leveraging a proprietary network of physicians, Bold Brain Capital aims to enhance the development and deployment of medical AI solutions that improve patient care and outcomes.
Community focus
The primary focus of Bold Brain Capital is on early-stage life sciences companies, particularly those that are developing transformational AI-enabled technologies. The firm typically engages in Seed through Series C funding rounds, emphasizing the critical role of physician involvement in the medical AI landscape.
Member value
Members of the Bold Brain Capital community benefit from unique investment opportunities alongside the firm in healthcare AI technologies. Additionally, they may access consulting opportunities within the firm's portfolio companies, enhancing their engagement in the evolving field of medical AI.
Membership
- Pricing models
- free
Format and cadence
- Modality
- in-person
- Schedule
- rolling-admissions
- Commitment
- light
Availability
- Membership state
- Accepting
Audience and fit
- Audience
- Founders · Investors · Corporate Innovators
- Benefits
- network-access and mentorship
- Program types
- community
- Selection criteria
- open
- Stages
- Seed · Series A · Series B · Series C
- Regions
- North America
Community activity
Notable members
The team includes notable members such as Mike Thomas, Tom Deur, MD, Robin Prasad, MD, MS, MBA, and Will Anlyan, all of whom bring extensive experience in healthcare and venture capital.
Common questions
What to know about Bold Brain Capital
Upseed classifies Bold Brain Capital under the Venture Capital organization type. Its current public profile includes funder and community capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.